Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rituximab plus Bendamustine as front line treatment in frail elderly (≥70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi (FIL) [Combinazione Rituximab-Bendamustina per il trattamento di I linea in soggetti anziani (≥70 anni) "fragili" affetti da Linfoma non Hodgkin a grandi cellule B: studio multicentrico di fase II della Fondazione Italiana Linfomi (FIL)]

Next Previous
X
Search
Trial Profile

Rituximab plus Bendamustine as front line treatment in frail elderly (≥70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi (FIL) [Combinazione Rituximab-Bendamustina per il trattamento di I linea in soggetti anziani (≥70 anni) "fragili" affetti da Linfoma non Hodgkin a grandi cellule B: studio multicentrico di fase II della Fondazione Italiana Linfomi (FIL)]

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 May 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bendamustine (Primary) ; Rituximab (Primary)
  • Indications Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Acronyms R-BENDA frail study

    • Most Recent Events

    • 09 Dec 2014 Interim results presented at the 56th Annual Meeting and Exposition of the American Society of Hematology.
    • 23 Nov 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01990144).
    • 07 Sep 2012 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top